Johnson & Johnson is one of the largest healthcare and consumer product companies in the world, employing 136,500 people. Revenues of between $88-90 billion are expected for 2021. Its three divisions comprise Consumer, Pharmaceutical, and Medical Devices.
Wealth Builder
Sorry!
Only current subscribers of the Internet Wealth Builder may view the details of this recommendation.
Income Investor
We took half profits a couple of years ago. The shares are down 5% over the last year, bringing its forward price/earnings ratio to below 15. The stock remains a Buy. - Gavin Graham
Sorry!
Only current subscribers of The Income Investor may view the details of this recommendation.
Interactive Performance Chart
JNJ was first recommended here on October 27, 2010